S.Amdt. 3054

SA 3054. Mr. ROBERTS (for himself and Mr. Kyl) submitted an amendment
intended to be proposed to amendment SA 2786 proposed by Mr. Reid (for
himself, Mr. Baucus, Mr. Dodd, and Mr. Harkin) to the bill H.R. 3590,
to amend the Internal Revenue Code of 1986 to modify the first-time
homebuyers credit in the case of members of the Armed Forces and
certain other Federal employees, and for other purposes; which was
ordered to lie on the table; as follows:

On page 1703, between lines 4 and 5, insert the following:

SEC. 6303. PROHIBITION ON THE USE OF COST IN COMPARATIVE
EFFECTIVENESS RESEARCH.

(a) In General.--Notwithstanding any other provision of
law, in no case may the cost of any medical treatment, item,
or service described in subsection (b) be considered a factor
in any comparative effectiveness research conducted--
(1) by the Federal Government; or
(2) by any other entity using funding provided by the
Federal Government.
(b) Medical Treatment, Item, or Service.--The medical
treatments, services, and items described in this subsection
are health care interventions, protocols for treatment, care
management, and delivery, procedures, medical devices,
diagnostic tools, pharmaceuticals (including drugs and
biologicals), integrative health practices, and any other
strategies or items being used in the treatment, management,
and diagnosis of, or prevention of illness or injury in,
individuals.
(c) Inclusion.--The comparative effectiveness research
described under subsection (a) includes any such research
conducted or funded by--
(1) the Patient-Centered Outcomes Research Institute under
section 1181 of the Social Security Act (as added by section
6301);
(2) the Department of Health and Human Services, including
the Agency for Healthcare Research and Quality and the
National Institutes of Health; and
(3) the Federal Coordinating Council for Comparative
Effectiveness Research established under section 804 of
Division A of the American Recovery and Reinvestment Act of
2009 (42 U.S.C. 299b-8).
(d) Application.--This section shall apply to any
comparative effectiveness research--
(1) that is ongoing as of the date of enactment of this
Act; or
(2) that is conducted after the date of enactment of this
Act.
______